DMAA

Drugs Made In America Acquisition Corp. Ordinary Shares
DMAA

Overview Fund Activity

32 hedge funds and large institutions have $212M invested in Drugs Made In America Acquisition Corp. Ordinary Shares in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
+8
Holders Change %
+33.33%
% of All Funds
0.43%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
10
Increased
8
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
WCMNY
1
Westchester Capital Management (New York)
New York
$17M
2
D.E. Shaw & Co
2
D.E. Shaw & Co
New York
$7.04M
3
HCM
3
Heights Capital Management
California
$6.63M
4
BFM
4
Boothbay Fund Management
New York
$5.81M
5
KIM
5
Karpus Investment Management
New York
$28M

Top Sellers

1
Toronto Dominion Bank
1
Toronto Dominion Bank
Ontario, Canada
$5.1M
2
QL
2
Quarry LP
New York
$0
3
DAM
3
DLD Asset Management
New York
$1.92M
4
CA
4
Crossingbridge Advisors
New York
$0
5
SSA
5
Schonfeld Strategic Advisors
New York
$1.52M
Name Holding Trade Value Shares
Change 		Shares
Change %
WAM
26
Warberg Asset Management
Illinois
$939K – – –
BI
27
Bulldog Investors
New Jersey
$744K +$744K +72,964 New
LSC
28
Logan Stone Capital
Illinois
$622K +$622K +60,991 New
VF
29
Virtu Financial
New York
$476K +$152K +14,908 +47%
Geode Capital Management
30
Geode Capital Management
Massachusetts
$466K +$1.9K +186 +0.4%
Morgan Stanley
31
Morgan Stanley
New York
$1.11K +$908 +89 +445%
UBS Group
32
UBS Group
Switzerland
$10 +$10 +1 New
CA
33
Crossingbridge Advisors
New York
– -$1.3M -850,000 Closed
QL
34
Quarry LP
New York
– -$6.51M -650,000 Closed
1
2